logo

For the Inventor, By the Inventor

Sundbyberg, Sweden

Biolamina Ab


USPTO Granted Patents = 21



Trademarks = 7

Forward Citations = 19

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Karl Kristian Tryggvason (14 out of 30 patents)

silverMedal Sergey Rodin (6 out of 7 patents)

bronzeMedal Anna Domogatskaya (5 out of 6 patents)

4.  Outi Hovatta (4 out of 4 patents)

5.  Kristian Tryggvason (4 out of 4 patents)

6.  Karl Tryggvason (3 out of 4 patents)

7.  Agnete Kirkeby (2 out of 2 patents)

8.  Malin Pernilla Parmar (2 out of 2 patents)

9.  Yan Wen Yap (2 out of 2 patents)

10.  Sun Yi (2 out of 2 patents)

11.  Louise Kristina Hagbard (2 out of 2 patents)

12.  Carl Gunnar Jesper Ericsson (2 out of 2 patents)

13.  Katherine Rachel Cameron (2 out of 2 patents)

14.  David Colin Hay (2 out of 3 patents)

15.  Stuart John Forbes (2 out of 2 patents)


21 patents:

1. 12516287 - Methods for producing retinal pigment epithelium cells (2026-01-06),
2. 12391915 - Maintenance of differentiated cells with laminins (2025-08-19),
3. 12378527 - Differentiation of pluripotent stem cells using laminins LN-511, LN-521 and LN-221 (2025-08-05),
4. 12195757 - Methods of producing RPE cells (2025-01-14),
5. 11767509 - Methods of producing RPE cells (2023-09-26),
6. 11713448 - Methods for producing hepatocytes (2023-08-01),
7. 11236302 - Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases (2022-02-01),
8. 11155781 - Maintenance of differentiated cells with laminins (2021-10-26),
9. 11001807 - Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221 (2021-05-11),
10. 10889801 - Methods of producing RPE cells (2021-01-12),
11. 10829733 - Composition and method for enabling proliferation of pluripotent human stem cells (2020-11-10),
12. 10683486 - Methods for producing hepatocytes (2020-06-16),
13. 10344259 - Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases (2019-07-09),
14. 10240124 - Cell culture substrate comprising a laminin and a cadherin (2019-03-26),
15. 10138292 - Cell culture medium (2018-11-27),
Biolamina AB is a leading biotech company dedicated to developing and producing advanced cell culture solutions. With a focus on human stem cells, Biolamina offers high-quality laminin-based products that enhance cell growth, proliferation, and differentiation. The company's innovative technologies are utilized by researchers and pharmaceutical companies worldwide to accelerate discoveries and advancements in regenerative medicine and drug discovery.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

21 Patents

#1 in Sundbyberg

#290 in Sweden

#29,088 in the World

...
Sundbyberg, Sweden

Biolamina Ab

Forward Citations = 19

20 inventors:

goldMedal Karl Kristian Tryggvason (14 out of 30 patents)

silverMedal Sergey Rodin (6 out of 7 patents)

bronzeMedal Anna Domogatskaya (5 out of 6 patents)

4.  Outi Hovatta (4 out of 4 patents)

5.  Kristian Tryggvason (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…